Virginia Commonwealth University
Also known as: Alexander Chi | Department of Physical Therapy, Virginia Commonwealth University | Leslie J. Cloud | Massey Cancer Center | Medical College of Virginia, Virginia Commonwealth University Medical Center | National Coordinator -Virginia Commonwealth University - Richmond - USA | VCU | VCU Health, Gastroenterology Hepatology and Nutrition, 1200 West Broad Street, Richmond VA23298, USA | VCU Health System | VCU Medical Center | Virginia Commonwealth University | Virginia Commonwealth University Department of Psychology, Institute for Drug and Alcohol Studies | Virginia Commonwealth University Health System | Virginia Commonwealth University Massey Cancer Center, McGlothlin Medical Education Center, Room 12-217, 1201 East Marshall St., PO Box 980070, Richmond, VA 23298-0070, USA | Virginia Commonwealth University Medical Center | Virginia Commonwealth University, Richmond, VA | Virginia Commonwealth University School of Medicine | Virginia Commonwealth University, USA | Virginia Commonweath School of Dentistry | Virignia Commonwealth University
Highest phase reached
Phase 4
First clinical trial
Oct 1, 1974Last known activity
Jan 25, 2026
Timeline
1960s
- Jan 1, 1968
Virginia Commonwealth University— Founded
Drugs by trial phase (235 distinct, 241 trials)
Phase 4 (45 own, 0 via acquisition)
Phase 3 (30 own, 0 via acquisition)
Phase 2 (86 own, 0 via acquisition)
Phase 1 (54 own, 0 via acquisition)
Other trials (20 own, 0 via acquisition)
Indications
Studied for
- Acute Lung Injury
- Adenocarcinoma
- Adenocarcinoma, Mucinous
- Adenocarcinoma of Lung
- Aggression
- Alcoholism
- Alcohol-Related Disorders
- Alzheimer Disease
- Anemia
- Anemia, Refractory
- Anemia, Refractory, with Excess of Blasts
- Anemia, Sickle Cell
- Anovulation
- Atrial Fibrillation
- Blast Crisis
- Bone Marrow Diseases
- Bone Neoplasms
- Brain Diseases
- Brain Injuries
- Brain Injuries, Traumatic
- Brain Neoplasms
- Breast Neoplasms
- Carcinoid Tumor
- Carcinoma
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Ovarian Epithelial
- Carcinoma, Renal Cell
- Carcinoma, Small Cell
- Carcinoma, Squamous Cell
- Carcinoma, Verrucous
- Cardiac Complexes, Premature
- Cardiomyopathies
- Cardio-Renal Syndrome
- Cardiovascular Diseases
- Chest Pain
- Cocaine-Related Disorders
- Cognitive Dysfunction
- Constipation
- Coronary Disease
- Craniocerebral Trauma
- Cystadenocarcinoma
- Cystic Fibrosis
- Cytomegalovirus Infections
- Dental Caries
- Depression
- Diabetes Mellitus
- Diabetes Mellitus, Type 1
- Diabetes Mellitus, Type 2
- Disease
- Drug Overdose
- Drug-Related Side Effects and Adverse Reactions
- Emergencies
- Esophageal and Gastric Varices
- Familial Primary Pulmonary Hypertension
- Fatigue
- Fatty Liver
- Fibrosis
- Fractures, Bone
- Gastrointestinal Hemorrhage
- Gastrointestinal Neoplasms
- Gastroparesis
- Glioblastoma
- Glioma
- Gliosarcoma
- Graft vs Host Disease
- Heart Diseases
- Heart Failure
- Heart Failure, Systolic
- Heart Valve Diseases
- Hemorrhage
- Hepatic Encephalopathy
- Hepatic Insufficiency
- Hepatitis
- Hepatitis A
- Hepatitis, Alcoholic
- Hepatitis, Autoimmune
- Hepatitis B
- Hepatitis C
- Hepatitis C, Chronic
- Hepatorenal Syndrome
- Hodgkin Disease
- Hot Flashes
- Hypercholesterolemia
- Hypersensitivity
- Hypertension
- Hypertension, Portal
- Hypertension, Pulmonary
- Hyperuricemia
- Hypotension
- Infarction
- Infections
- Inflammation
- Insulin Resistance
- Intervertebral Disc Degeneration
- Ischemia
- Kidney Diseases
- Kidney Failure, Chronic
- Kidney Neoplasms
- Leukemia
- Leukemia, Lymphocytic, Chronic, B-Cell
Recent trials (50)
- NCT07284290Lead sponsorPhase 4Jan 25, 2026
- NCT07284290OfficialPhase 4Jan 25, 2026
- NCT07130695OfficialPhase 1Oct 31, 2025
- NCT07130695Lead sponsorPhase 1Oct 31, 2025
- NCT06966388OfficialPhase 1Aug 13, 2025
- NCT06966388Lead sponsorPhase 1Aug 13, 2025
- NCT06846463Lead sponsorPhase 2Jun 30, 2025
- NCT06846463OfficialPhase 2Jun 30, 2025
- NCT06981195Lead sponsorPhase 2May 27, 2025
- NCT06771323Lead sponsorPhase 2Mar 31, 2025
- NCT06771323OfficialPhase 2Mar 31, 2025
- NCT06874192Lead sponsorPhase 1Mar 12, 2025
- NCT06874192OfficialPhase 1Mar 12, 2025
- NCT06728072Lead sponsorPhase 2Dec 15, 2024
- NCT06728072OfficialPhase 2Dec 15, 2024
Details
- Founded
- Richmond, Virginia, US Jan 1, 1968
- Last known activity
- Jan 25, 2026